Heat shock protein-90 inhibitor, NVP-AUY922, is effective in combination with fludarabine against chronic lymphocytic leukemia cells cultured on CD40L-stromal layer and inhibits their activated/proliferative phenotype.

Abstract excerpt

Chronic lymphocytic leukemia (CLL) involves disease infiltration into active proliferation centers within the lymph nodes and marrow. Successful treatment of CLL must involve targeting the leukemic cells in these supportive microenvironments. Our recent data suggest that inhibition of heat shock...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to CD40 Antigens
• Share to CD40 Ligand
• Share to HSP90 Heat-Shock Proteins